Dr. Bachnoff graduated from the Hebrew University of Jerusalem and received a PhD degree from the faculty of natural sciences in the field of molecular and structural biochemistry. Dr. Bachnoff is a founding partner of Omnix Medical and has been leading the R&D team in their activities from early discovery stages and up-to present achievements. Dr. Bachnoff is the major designer and developer of Omnix Medicals' Antimicrobial Peptides technology. He is an expert microbiologist and has vast experience in peptide-based drug design and the development of native-peptides for therapeutic applications.
Dr. Bachnoff is the co-inventor of two registered patents pertaining to Omnix technology:
- US Patent No. 10,308,693 B2 ANTIMICROBIAL PEPTIDES
- EU Patent No. EP 3 197 479 B1 ANTIMICROBIAL PEPTIDES
Dr. Bachnoff is instrumental to managing the work of numerous CROs in EU and US as well as all activities involving regulatory authorities. In addition, he is in-charge of all non-dilutive funding and has secured more than 2.5M from the Israeli government, through the Israel Innovation Authority (IIA) and The Jerusalem Development authority (JDA).
Omnix Medical - Resistance Is Not An Option
Niv Bachnoff is currently associated with Omnix Medical, a company in the health tech sector. With a background in education from The Hebrew University, Niv is positioned in a role that likely leverages his academic experience.
Professional Experience
0y
Role Type
Industry
Organization Type
Career-Linked Companies in Finder
Companies from this member’s experience that have profiles in Finder